Showing results (1401-1410 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|May 28, 2010
Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectivesBruno Vincenzi, Andrea Napolitano, Anna Maria Frezza, et al.
Pharmacogenomics|May 28, 2010
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysisSae-Hoon Kim, Myunghwa Kim, Kyung Wha Lee, et al.
Pharmacogenomics|February 12, 2009
Family-based genome-wide association studiesBeben Benyamin, Peter M Visscher, Allan F McRae
Pharmacogenomics|November 5, 2010
CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifenRikje Ruiter, Monique J Bijl, Ron H N van Schaik, et al.
Pharmacogenomics|April 1, 2011
Risk modeling strategies for pharmacogenetic studiesAndrea L Jorgensen, Munir Pirmohamed
Pharmacogenomics|April 1, 2011
Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemiaJennifer G Gaultney, Enrique Sanhueza, Jeroen J Janssen, et al.
Pharmacogenomics|April 1, 2011
Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapyRobert H Goertsches, Uwe K Zettl, Michael Hecker
Pharmacogenomics|April 1, 2011
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypesJatinder K Lamba, Kristine R Crews, Stanley B Pounds, et al.
Pharmacogenomics|April 1, 2011
Central neurotoxicity in cancer chemotherapy: pharmacogenetic insightsFemke E A M Froklage, Jaap C Reijneveld, Jan J Heimans
Pharmacogenomics|May 13, 2015
Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic reviewSamantha Jarjour, Mathieu Barrette, Valérie Normand, et al.
Pageof 276